To market, to market-2013

Annual Reports in Medicinal Chemistry

Volumn 49, Issue , 2014, Pages 437-508

  Bronson, Joanne ^a   Black, Amelia ^b   Dhar, Murali ^a   Ellsworth, Bruce ^a   Robert Merritt, J ^c  

^a BRISTOL MYERS SQUIBB   (United States)

^b Bristol Myers Squibb   (United States)

^c KEAN UNIVERSITY   (United States)

Author keywords

Acotiamide; Ado trastuzumab emtansine; Afatinib; Canagliflozin; Cetilistat; Cobicistat; Dabrafenib; Dimethyl fumarate; Dolutegravir; Efinaconazole; Elvitegravir; Ibrutinib; Istradefylline; Lixisenatide; Macitentan; Metreleptin; Mipomersen; Obinutuzumab; Olodaterol; Ospemifene; Pomalidomide; Saroglitazar; Simeprevir; Sofosbuvir; Trametinib; Vortioxetine

Indexed keywords

EID: 84907558618     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800167-7.00027-4     Document Type: Chapter

References (258)

1. Mullard A. Nature Rev. Drug Discov. 2013, 13:85.
2. Agrawal R. Curr. Drug Targets 2014, 15:151.
3. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203414s000lbl.pdf.
4. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022426s000lbl.pdf.
5. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203137s000lbl.pdf.
6. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203975s000lbl.pdf.
7. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204275s000lbl.pdf.
8. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002679/WC500151255.pdf.
9. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204251s000lbl.pdf.link.
10. Tack J., Talley N.J. Nat. Rev. Gastroenterol. Hepatol. 2013, 10:134.
11. Tack J., Talley N.J., Camilleri M., Holtmann G., Hu P., Malagelada J.-R., Stanghellini V. Gastroenterology 2006, 130:1466.
12. Matsunaga Y., Tanaka T., Yoshinaga K., Ueki S., Hori Y., Eta R., Kawabata Y., Yoshii K., Yoshida K., Matsumura T., Furuta S., Takei M., Tack J., Itoh Z. J. Pharmacol. Exp. Ther. 2011, 336:791.
13. Seto K., Sasaki T., Katsunuma K., Kobayashi N., Tanaka K., Tack J. Neurogastroenterol. Motil. 2008, 20:1051.
14. Nagasawa, M.; Murata, M.; Nishioka, H.; Kurimoto, T.; Ueki, S.; Kitagawa, O. US Patent 5,981,557, 1999.
15. Nolan M.L., Scott L.J. Drugs 2013, 73:1377.
16. Matsueda K., Hongo M., Tack J., Saito Y., Kato H. Gut 2012, 61:821.
17. Boyraz B., Sendur M.A.N., Aksoy S., Babacan T., Roach E.C., Kizilarslanoglu M.C., Petekkaya I., Altundag K. Curr. Med. Res. Opin. 2013, 29:405.
18. Hurvitz S.A., Dirix L., Kocsis J., Bianchi G.V., Lu J., Vinholes J., Guardino E., Song C., Tong B., Ng V., Chu Y., Perez E.A. J. Clin. Oncol. 2013, 31:1157.
19. Krop I., Winer E.P. Clin. Cancer Res. 2014, 20:15.
20. Girish S., Gupta M., Wang B., Lu D., Krop I.E., Vogel C.L., Burris H.A., LoRusso P.M., Yi J., Saad O., Tong B., Chu Y., Holden S., Joshi A. Cancer Chemother. Pharmacol. 2012, 69:1229.
21. Verma S., Miles D., Gianni L., Krop I.E., Welslau M., Baselga J., Pegram M., Oh D., Diéras V., Guardino E., Fang L., Lu M.W., Olsen S., Blackwell K. N. Engl. J. Med. 2012, 367:1783.
22. Siegel R., Naishadham D., Jemal A. Cancer J. Clin. 2012, 62:10.
23. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer 2012, National Comprehensive Cancer Network, Available from:. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
24. Riely G.J., Politi K.A., Miller V.A., Pao W. Clin. Cancer Res. 2006, 12:7232.
25. Li D., Ambrogio L., Shimamura T., Kubo S., Takahashi M., Chirieac L.R., Padera R.F., Shapiro G.I., Baum A., Himmelsbach F., Rettig W.J., Meyerson M., Solca F., Greulich H., Wong K.K. Oncogene 2008, 27:4702.
26. Schroeder, J.; Dziewas, G.; Fachinger, T.; Jaeger, B.; Reichel, C.; Renner, S. WO Patent Application 2007/085638, 2007.
27. Dungo R.T., Keating G.M. Drugs 2013, 73:1503.
28. Sequist L.V., Yang J.C.-H., Yamamoto N., O'Byrne K., Hirsh V., Mok T., Geater S.L., Orlov S., Tsai C.-H., Boyer M., Su W.-C., Bennouna J., Kato T., Gorbunova V., Lee K.H., Shah R., Massey D., Zazulina V., Shahidi M., Schuler M. J. Clin. Oncol. 2013, 31:3327.
29. (last accessed 19.02.2014). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm.
30. (last accessed 19.02.2014). http://www.who.int/mediacentre/factsheets/fs312/en/.
31. Devitt M. Am. Fam. Physician 2013, 87:140.
32. Tsujihara T., Hongu M., Saito K., Kawanishi H., Kuriyama K., Matsumoto M., Oku A., Ueta K., Tsuda M., Saito A. J. Med. Chem. 1999, 42:5311.
33. Nomura S., Sakamaki S., Hongu M., Kawanishi E., Koga Y., Sakamoto T., Yamamoto Y., Ueta K., Kimata H., Nakayama K., Tsuda-Tsukimoto M. J. Med. Chem. 2010, 53:6355.
34. Ellsworth, B.; Washburn, W.; Sher, P.; Wu, G.; Meng, W. US Patent 6,414,126, 2002.
35. Meng W., Ellsworth B., Nirschl A., McCann P., Patel M., Girotra R., Wu G., Sher P., Morrison E., Biller S., Zahler R., Deshpande P., Pullockaran A., Hagan D., Morgan N., Taylor J., Obermeier M., Humphreys W., Khanna A., Discenza L., Robertson J., Wang A., Han S., Wetterau J., Janovitz E., Flint O., Whaley J., Washburn W. J. Med. Chem. 2008, 51:1145.
36. Scheen A. Clin. Pharmacokinet. 2014, 53:213.
37. Devineni D., Curtin C., Polidori D., Gutierrez M., Murphy J., Rusch S., Rothenberg P. J. Clin. Pharmacol. 2013, 53:601.
38. Stenlo K., Cefalu W., Kim K., Alba M., Usiskin K., Tong C., Canovatchel W., Meininger G. Diabetes Obes. Metab. 2012, 15:372.
39. Rosenstock J., Aggarwal N., Polidori D., Zhao Y., Arbit D., Usiskin K., Capuano G., Canovatchel W. Diabetes Care 2012, 35:1232.
40. Cefalu W., Leiter L., Yoon K., Arias P., Niskanen L., Xie J., Balis D., Canovatchel W., Meininger G. Lancet 2013, 382:941.
41. (last accessed 28.02.2014). http://www.invokanahcp.com/prescribing-information.pdf.
42. Takeda Pharmaceuticals Press Release, (20.09.2013). http://www.takeda.com/news/2013/20130920_5991.html.
43. WHO Global Health Observatory, (last accessed 11.03.2014). http://www.who.int/gho/ncd/risk_factors/overweight/en/.
44. Bray G.A. J. Med. Chem. 2006, 49:4001.
45. Yanovski S.Z., Yanovski J.A. J. Am. Med. Assoc. 2013, 311:74.
46. Hodson, H.; Downham, R.; Mitchell, T.J.; Carr, B.J.; Dunk, C.R.; Palmer, R.M.J. US Patent 6,656,934, 2003.
47. Yamada Y., Kato T., Ogino H., Ashina S., Kato K. Horm. Metab. Res. 2008, 40:539.
48. Padwal R. Curr. Opin. Investig. Drugs 2008, 9:414.
49. Bryson A., de la Motte S., Dunk C. Br. J. Clin. Pharmcol. 2009, 67:309.
50. Kopelman P., Bryson A., Hickling R., Rissanen A., Rossner S., Toubro S., Valensi P. Int. J. Obes. 2007, 31:494.
51. Kopelman P., Groot G., de H., Rissanen A., Rossner S., Toubro S., Palmer R., Hallam R., Bryson A., Hickling R.I. Obesity 2009, 18:108.
52. http://www.gilead.com/news/press-releases/2013/9/european-commission-approves-gilead-sciences-tybost-a-new-boosting-agent-for-hiv-therapy.
53. http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002572/WC500146622.pdf.
54. http://www.who.int/gho/hiv/en/.
55. Xu L., Liu H., Murray B.P., Callebaut C., Lee M.S., Hong A., Strickley R.G., Tsai L.K., Stray K.M., Wang Y., Rhodes G.R., Desai M.C. ACS Med. Chem. Lett. 2010, 1:209.
56. Mathias A.A., German P., Murray B.P., Wei L., Jain A., West S., Warren D., Hui J., Kearney B.P. Nature 2010, 87:322.
57. Shah B.M., Schafer J.J., Priano J., Squires K.E. Pharmacotherapy 2013, 33:1107.
58. Gallant J.E., Koenig E., Andrade-Villanueva J., Chetchotisakd P., DeJesus E., Antunes F., Arastéh K., Moyle G., Rizzardini G., Fehr J., Liu Y., Zhong L., Callebaut C., Szwarcberg J., Rhee M.S., Cheng A.K. J. Infect. Dis. 2013, 208:32.
59. Stellwagen J., Adjabeng G., Arnone M., Dickerson S., Han C., Hornberger K., King A., Mook R., Petrov K., Rheault T., Rominger C., Rossanese O., Smitheman K., Waterson A., Uehling D. Bioorg. Med. Chem. Lett. 2011, 21:4436.
60. Rheault T.R., Stellwagen J.C., Adjabeng G.M., Hornberger K.R., Petrov K.G., Waterson A.G., Dickerson S.H., Mook R.A., Laquerre S.G., King A.J., Rossanese O.W., Arnone M.R., Smitheman K.N., Kane-Carson L.S., Han C., Moorthy G.S., Moss K.G., Uehling D.E. ACS Med. Chem. Lett. 2013, 4:358.
61. Laquerre S., Arnone M., Moss K., Yang J., Fisher K., Kane-Carson L.S., Smitheman K., Ward J., Heidrich B., Rheault T., Adjabeng G., Hornberger K., Stellwagen J., Waterson A., Han C., Mook R.A., Uehling D., King A.J. 2009, Abstract B88.
62. Adams, J. L.; Dickerson, S. H.; Johnson, N. W.; Kuntz, K.; Petrov, K.; Ralph, J. M.; Rheault, T. R.; Schaaf, G.; Stellwagen, J.; Tian, X.; Uehling, D. E.; Waterson, A. G.; Wilson, B. WO Patent Application 2009/137391, 2009.
63. GlaxoSmithKline. Tafinlar® (Dabrafenib Capsules): US Prescribing Information, 2013. http://us.gsk.com/products/assets/us_tafinlar.pdf.
64. Hauschild A., Grob J.-J., Demidov L.V., Jouary T., Gutzmer R., Millward M., Rutkowski P., Blank C.U., Miller W.H., Kaempgen E., Algarra S.-M., Karaszewska B., Mauch C., Chiarion-Sileni V., Martin A.-M., Swann S., Haney P., Mirakhur B., Guckert M.E., Goodman V., Chapman P.B. Lancet 2012, 380:358.
65. (last accessed 29.01.2014). http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204063Orig1s000ltr.pdf.
66. (last accessed 29.01.2014). http://www.nationalmssociety.org/about-the-society/ms-prevalence/index.aspx.
67. Sobieraj D., Coleman C. Formulary 2012, 47:386.
68. Wilson A., Kerns J., Callahan J., Moody C. J. Med. Chem. 2013, 56:7463.
69. Mrowietz U., Asadullah K. Trends Mol. Med. 2005, 11:43.
70. Schimrigh S., Brune N., Hellwig K., Lukas C., Bellenberg B., Rieks, Hoffmann V., Pohlau D., Przuntek H. Eur. J. Neurol. 2006, 13:604.
71. Schilling S., Goelz S., Linker R., Luehder F., Gold R. Clin. Exp. Immunol. 2006, 145:101.
72. Guzowski, J.; Kiesman, W.; Irdam, E. Patent Application WO2012/170923, 2012.
73. Litjens N., Burggraaf J., van Strijen E., van Gulpen C., Mattie H., Schoemaker R., van Dissel J., Thio H., Nibbering P. Br. J. Clin. Pharmacol. 2004, 58:429.
74. Werdenberg D., Joshi R., Wolffram S., Merkle H., Langguth P. Biopharm. Drug Dispos. 2003, 24:259.
75. (last accessed 29.01.2014). http://www.tecfidera.com/pdfs/full-prescribing-information.pdf.
76. Kappos L., Gold R., Miller D., MacManus D., Havrdova E., Limmroth V., Polman C., Schmierer K., Yousry T., Yang M., Eraksoy M., Meluzinova E., Rektor I., Dawson K., Sandrock A., O'Neill G. Lancet 2008, 372:1463.
77. Giovannoni G., Gold R., Kappos L., Arnold D., Bar-Or A., Selmaj K., Zhang A., Sheikh S., Dawson K. Neurology 2012, 78. PD5.005. (AAN Meeting Abstracts).
78. Fox R., Miller D., Phillips T., Kita M., Hutchinson M., Havrdova E., Yang M., Zhang R., Viglietta V., Dawson K. Neurology 2012, 78. S01.003 (AAN Meeting Abstracts).
79. Atal S., Atal S. Int. J. Basic Clin. Pharmacol. 2013, 2:849.
80. (last accessed 28.02.2014). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm364744.htm.
81. (last accessed 28.02.2014). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
82. Hare S., Smith S., Métifiot M., Jaxa-Chamiec A., Pommier Y., Hughes S., Cherepanov P. Mol. Pharmacol. 2011, 80:565.
83. Wai J., Egbertson M., Payne L., Fisher T., Embrey M., Tran L., Melamed J., Langford H., Guare J., Zhuang L., Grey V., Vacca J., Holloway M., Naylor-Olsen A., Hazuda D., Felock P., Wolfe A., Stillmock K., Schleif W., Gabryelski L., Young S. J. Med. Chem. 2000, 43:4923.
84. Johns B., Kawasuji T., Weatherhead J., Taishi T., Temelkoff D., Yoshida H., Akiyama T., Taoda Y., Murai H., Kiyama R., Fuji M., Tanimoto N., Jeffrey J., Foster S., Yoshinaga T., Seki T., Kobayashi M., Sato A., Johnson M., Garvey E., Fujiwara T. J. Med. Chem. 2013, 56:5901.
85. Raffi F., Rachlis A., Stellbrink H.-J., Hardy W., Torti C., Orkin C., Bloch M., Podzamczer D., Pokrovsky V., Pulido F., Almond S., Margolis D., Brennan C., Min S. Lancet 2013, 381:735.
86. Cahn P., Pozniak A., Mingrone H., Shuldyakov A., Brites C., Andrade-Villanueva J., Richmond G., Buendia C., Fourie J., Ramgopal M., Hagins D., Felizart F., Madruga J., Reuter T., Newman T., Small C., Lombaard J., Grinsztejn B., Dorey D., Underwood M., Griffith S., Min S. Lancet 2013, 382:700.
87. Min S., Song I., Borland J., Chen S., Lou Y., Fujiwara T., Piscitelli S. Antimicrob. Agents Chemother. 2010, 54:254.
88. Reese M., Savina P., Generaux G., Tracey H., Humphreys J., Kanaoka E., Webster L., Harmon K., Clarke J., Polli J. Drug Metab. Dispos. 2013, 41:353.
89. Rathbun R., Lockhart S., Miller M., Liedtke M. Ann. Pharmacother. 2013, 20:1.
90. (last accessed 21.03.2014). http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204790lbl.pdf.
91. Patel T., Dhillon S. Drugs 2013, 73:1977.
92. Thomas J., Jacobson G.A., Narkowicz C.K., Peterson G.M., Burnet H., Sharpe C. J. Clin. Pharm. Ther. 2010, 35:497.
93. Tatsumi Y., Nagashima M., Shibanushi T., Iwata A., Kangawa Y., Inui F., Jo Siu W.J., Pillai R., Nishiyama Y. Antimicrob. Agents Chemother. 2013, 57:2405.
94. Tatsumi Y., Yokoo M., Arika T. Antimicrob. Agents Chemother. 2001, 45:1493.
95. Ogura H., Kobayashi H., Nagai K., Nishida T., Naito T., Tatsumi Y., Yokoo M., Arika T. Chem. Pharm. Bull 1999, 47:1417.
96. Mimura, M.; Watanabe, M.; Ishiyama, N.; Yamada, T. WO2012029836, 2012.
97. Jarratt M., Jo Siu W., Yamakawa E., Kodera N., Pillai R., Smith K. J. Drugs Dermatol. 2013, 12:1010.
98. Elewski B.E., Rich P., Pollak R., Pariser D.M., Watanabe S., Senda H., Ieda C., Smith K., Pillasi R., Ramakrishna T., Olin J.T. J. Am. Acad. Dermatol. 2013, 68:600.
99. (last accessed 26.03.2014). http://www.gilead.com/news/press-releases/2013/11/european-commission-approves-gileads-vitekta-an-integrase-inhibitor-for-the-treatment-of-hiv1-infection.
100. (last accessed 26.03.2014). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm317004.htm.
101. Hazuda D., Young S., Guare J., Anthony N., Gomez R., Wai J., Vacca J., Handt L., Motzel S., Klein H., Dornadula G., Danovich R., Witmer M., Wilson K., Tussey L., Schleif W., Gabryelski L., Jin L., Miller M., Casimiro D., Emini E., Shiver J. Science 2004, 305:528.
102. Sato M., Motomura T., Aramaki H., Matsuda T., Yamashita M., Ito Y., Kawakami H., Matsuzaki Y., Watanabe W., Yamataka K., Ikeda S., Kodama E., Matsuoka M., Shinkai H. J. Med. Chem. 2006, 49:1506.
103. DeJesus E., Berger D., Markowitz M., Cohen C., Hawkins T., Ruane P., Elion R., Farthing C., Zhong L., Cheng A., McColl D., Kearney B. J. Acquir. Immune Defic. Syndr. 2006, 43:1.
104. Ramanathan S., Shen G., Cheng A., Kearney B. J. Acquir. Immune Defic. Syndr. 2007, 44:274.
105. DeJesus E., Rockstroh J., Henry K., Molina J., Gathe J., Ramanathan S., Wei X., Yale K., Szwarcberg J., White K., Cheng A., Kearney B. Lancet 2012, 379:2429.
106. (last accessed 28.03.2014). http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203100s000lbl.pdf.
107. Molina J., LaMarca A., Andrade-Villanueva J., Clotet B., Clumeck N., Liu Y., Zhong L., Margot N., Cheng A., Chuck S. Lancet 2012, 12:27.
108. (last accessed 28.03.2014). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002577/WC500155576.pdf.
109. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., Linet M.S. Blood 2006, 107:265.
110. Honigberg L.E., Smith A.M., Sirisawad M., Verner E., Loury D., Chang B., Li S., Pan Z., Thamm D.H., Miller R.A., Buggy J.J. Proc. Natl. Acad. Sci. 2010, 107:13075.
111. Pan Z., Scheerens H., Li S., Schultz B.E., Sprengeler P.A., Burrill L.C., Mendonca R.V., Sweeney M.D., Scott K.C.K., Grothaus P.G., Jeffery D.A., Spoerke J.M., Honigberg L.A., Young P.R., Dalrymple S.A., Palmer J.T. ChemMedChem 2007, 2:58.
112. Honigberg, L.; Verner, E.; Pan, Z. US Patent Application 0076921, 2008.
113. http://www.dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0dfd0279-ff17-4ea9-89be-9803c71bab44.(last accessed 22.02.2014).
114. Sukbunthemg, J.; Jejukar, P.; Chan, S.; Tran, A. L.; Moussa, D.; James, D. F.; Loury, D. In: ASCO Annual Meeting; Chicago, IL. 2013. Abstract 7056.
115. Wang M.L., Rule S., Martin P., Goy A., Auer R., Kahl B.S., Jurczak W., Advani R.H., Romaguera J.E., Williams M.E., Barrientos J.C., Chmielowska E., Radford J., Stilgenbauer S., Dreyling M., Jedrzejczak W.W., Johnson P., Spurgeon S.E., Li L., Zhang L., Newberry K., Ou Z., Cheng N., Fang B., McGrivy J., Clow F., Buggy J.J., Chang B.Y., Beaupre D.M., Kunkel L.A., Blum K.A. N. Engl. J. Med. 2013, 369:507.
116. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm385764.html.
117. Dungo R., Deeks E.D. Drugs 2013, 73:875.
118. World Health Organization Report on Neurological Disorders: Public Health Challenges, 2006, 140. http://www.who.int/mental_health/neurology/neurological_disorders_report_web.pdf.
119. Shimada J., Koike N., Nonaka H., Shiozaki S., Yanagawa K., Kanda T., Kobayashi H., Ishimura M., Nakamura J., Kase H., Suzuki F. Bioorg. Med. Chem. Lett. 1997, 18:2349.
120. Saki M., Yamada K., Koshimura E., Sasaki K., Kanda T. Naunyn-Schmiedebergs Arch. Pharmacol. 2013, 386:963.
121. Jenner P. Expert Opin. Investig. Drugs 2005, 14:729.
122. Knebel W., Rao N., Uchimura T., Mori A., Fisher J., Gastonguay M.R., Chaikin P. J. Clin. Pharmacol. 2011, 51:40.
123. Brooks D.J., Doder M., Osman S., Luthra S.K., Hirani E., Hume S., Kase H., Kilborn J., Martindill S., Mori A. Synapse 2008, 62:671.
124. Mizuno Y., Kondo T. Movement Disord. 2013, 28:1138. The Japanese Istradefylline Study Group.
125. IDF Diabetes Atlas 2012, International Diabetes Federation, International Diabetes Federation, Brussels, Belgium. http://www.idf.org/diabetesatlas, 5th ed.
126. American Diabetes Association website. http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/oral-medications/what-are-my-options.html.
127. Rotenstein L.S., Kozak B.M., Shivers J.P., Yarchoan M., Close J., Close K.L. Clin. Diabetes 2012, 30:44.
128. Petersen A.B., Christensen M. Diabetes Metab. Syndr. Obes. 2013, 6:217.
129. Parkes D.G., Mace K.F., Trautmann M.E. Expert Opin. Drug Discov. 2013, 8:219.
130. Christensen M., Knop F.K., Vilsboll T., Holst J.J. Expert Opin. Investig. Drugs 2011, 20:549.
131. Thorkildsen C., Neve S., Larsen B.D., Meier E., Petersen J.S. J. Pharmacol. Exp. Ther. 2003, 307:490.
132. Committee for Medicinal Products for Human Use, European Medicines Agency, Assessment Report EMA/CHMP/703852/2012.
133. Committee for Medicinal Products for Human Use, European Medicines Agency, Summary of Opinion, EMA/CHMP/706420/2012.
134. Temple R. US FDA Approval Letter 2013, CDER, Silver Spring, MD.
135. Farber H.W., Loscalzo J. N. Engl. J. Med. 2004, 351:1655.
136. Sutendra G., Michelakis E.D. Sci. Transl. Med. 2013, 5:1.
137. Ahmed S., Palevsky H.I. Rheum. Dis. Clin. N. Am. 2014, 40:103.
138. Bolli M.H., Boss C., Binkert C., Buchmann S., Bur D., Hess P., Iglarz M., Meyer S., Rein J., Rey M., Treiber A., Clozel M., Fishli W., Weller T. J. Med. Chem. 2012, 55:7849.
139. Bruderer S., Hopfgartner G., Seiberling M., Wank J., Sidharta P.N., Treiber A., Dingemanse J. Xenobiotica 2012, 42:901.
140. Pulido T., Adzerikho I., Channick R.N., Delcroix M., Galie N., Ghofrani H.-A., Jansa P., Jing Z.-C., Le Brun F.-O., Mehta S., Mettelholzer C.M., Perchenet L., Sastry B.K.S., Sitbon O., Souza R., Torbicki A., Zeng X., Rubin L.J., Simonneau G. N. Engl. J. Med. 2013, 369:809.
141. Garg A. N. Engl. J. Med. 2004, 350:1220.
142. Chan J.L., Oral E.A. Endocrine Pract. 2010, 16:310.
143. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Science 1995, 269:540.
144. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Nature 1994, 372:425.
145. Shimomura I., Hammer R.E., Ikemoto S., Brown M.S., Goldstein J.L. Nature 1999, 401:73.
146. Myalept label, downloaded from:. http://www.myalept.com/index.aspx.
147. Chou K., Perry C.M. Drugs 2013, 73:989.
148. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A.J., DePaoli A.M., Reitman M.L., Taylor S.I., Gorden P., Garg A. N. Engl. J. Med. 2002, 346:570.
149. Diabetes Care 2014, 37:S14. American Diabetes Association.
150. Zadeh E.S., Lungu A.O., Cochran E.K., Brown R.J., Ghany M.G., Heller T., Kleiner D.E., Gorden P. J. Hepatol. 2013, 59:131.
151. http://www.pmda.go.jp/english/service/pdf/drugs/metreleptin_mar2013_e.pdf.
152. Liscinsky, M. US FDA Press Release, February 25, 2014. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm387060.htm.
153. Kynamro Prescribing Label. http://www.fda.gov/downloads/drugs/drugsafety/ucm337730.pdf.
154. Raal F.J., Santos R.D. Atherosclerosis 2012, 223:262-268.
155. Cuchel M., Meagher E.A., Theron H.d.T., Blom D.J., Marais A.D., Hegele R.A., Averna M.R., Sirtori C.R., Shah P.K., Gaudet D., Stefanutti C., Vigna G.B., Du Plessis A.M.E., Propert K.J., Sasiela W.J., Bloedon L.T., Rader D.J. Lancet 2013, 381:40.
156. Crooke S.T., Geary R.S. Br. J. Clin. Pharmacol. 2012, 76:269.
157. Seth P.P., Siwkowski A., Allerson C.R., Vasquez G., Lee S., Prakash T.P., Wancewicz E.V., Witchell D., Swayze E.E. J. Med. Chem. 2009, 52:10.
158. Krotz A., Gorman D., Mataruse P., Foster C., Godbout J.D., Coffin C.C., Scozzari A.N. Org. Process Res. Dev. 2004, 8:852.
159. Mullick A.E., Fu W., Graham M.J., Lee R.G., Witchell D., Bell T.A., Whipple C.P., Crooke R.M. J. Lipid Res. 2011, 52:885.
160. Merki E., Graham M.J., Mullick A.E., Miller E.R., Crooke R.M., Pitas R.E., Witztum J.L., Tsimikas S. Circulation 2008, 118:743.
161. Beck A., Reichert J.M. MAbs 2012, 4:419.
162. Sehn L.H., Assouline S.E., Stewart D.A., Mangel J., Gayscoyne R.D., Fine G., Frances-Lasserre S., Carlile D.J., Crump M. Blood 2012, 119:5118.
163. Dalle S., Reslan L., Besseyre de Horts T., Herveau S., Herting F., Plesa A., Friess T., Umana P., Klein C., Dumontet C. Mol. Cancer Ther. 2011, 10:178.
164. Herter S., Herting F., Mundigi O., Waldhauer I., Weinzieri T., Fauti T., Muth G., Ziegler-Landesberger D., Van Puijenbroek E., Lang S., Duong M.N., Reslan L., Gerdes C.A., Friess T., Baer U., Burtscher H., Weidner M., Dumonte C., Umana P., Niederfellner G., Bacac M., Klein C. Mol. Cancer Ther. 2013, 12:2031.
165. Cameron F., McCormack P.L. Drugs 2014, 74:147.
166. Goede V., Fischer K., Busch R., Engelke A., Eichhorst B., Wendtner C.M., Chagorova T., de la Serna J., Dilhuydy M., Illmer T., Opat S., Owen C.J., Samoylova O., Kreuzer K., Stilgenbauer S., Döhner H., Langerak A.W., Ritgen M., Kneba M., Asikanius E., Humphrey K., Wenger M., Hallek M. N. Engl. J. Med. 2014, 370:1101.
167. Gibb A., Yang L.P.H. Drugs 2013, 73:1841.
168. Mannino D.M., Buist A.S. Lancet 2007, 370:765.
169. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
170. http://www.who.int/mediacentre/factsheets/fs315/en/.
171. Bouyssou T., Hoenke C., Rudolf K., Lustenberger P., Pestel S., Sieger P., Lotz R., Heine C., Büttner F.H., Schnapp A., Konetzki I. Bioorg. Med. Chem. Lett. 2010, 20:1410.
172. Bouyssou T., Casarosa P., Naline E., Pestel S., Konetzki I., Devillier P., Schnapp A. J. Pharmacol. Exp. Ther. 2010, 334:53.
173. Casarosa P., Kollak I., Kiechle T., Ostermann A., Schnapp A., Kiesling R., Pieper M., Sieger P., Gantner F. J. Pharmacol. Exp. Ther. 2011, 337:600.
174. Van Noord J.A., Smeets J.J., Drenth B.M., Rascher J., Pivovarova A., Hamilton A.L., Cornelissen P.J.G. Pulmon. Pharmacol. Ther. 2011, 24:666.
175. Ferguson, G.; Feldman, G; Hofbauer, P.; Hamilton, A.; Allen, L.; Korducki, L.; Sachs, P. Annual Congress of the European Respiratory Society; Barcelona, Spain, 2013. Abstract no. 187.
176. Koch, A.; Pizzichini, E.; Hamilton, A.; Hart, L.; Korducki, L.; De Salvo, M. C.; Paggiaro, P. Annual Congress of the European Respiratory Society; Barcelona, Spain, 2013, Abstract no. 764.
177. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2013_striverdi_respimat_155649-eng.php.
178. Williams R.E., Levine K.B., Kalilani L., Lewis J., Clark R.V. Maturitas 2009, 62:153.
179. Qu Q., Zheng H., Dahllund J., Laine A., Cockcroft N., Peng Z., Koskinen M., Hemminki K., Kangas L., Vaananen K., Harkonen P. Endocrinology 2000, 141:809.
180. Unkila M., Kari S., Yatkin E., Lammintausta R. J. Steroid Biochem. Mol. Biol. 2013, 138:107.
181. Eklund, L.; Nilsson, J. WO Patent Application 2011/089385, 2011.
182. http://www.dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8462d6ab-e3cd-4efa-a360-75bf8f917287 (last accessed 22.02.2014).
183. Bachmann G.A., Komi J.O. Menopause 2010, 17:480. Ospemifene Study Group.
184. Portman D.J., Bachmann G.A., Simon J.A. Menopause 2013, 20:623. Ospemifene Study Group.
185. (last accessed 4.02.2014). http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm338895.htm.
186. (last accessed 4.02.2014). http://seer.cancer.gov/statfacts/html/mulmy.html.
187. Rajkumar S. Nat. Rev. Clin. Oncol. 2011, 8:479.
188. (last accessed 11.02.2014). http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide.
189. (last accessed 11.02.2014). http://www.thalomid.com/pdf/thalomid_pi.pdf.
190. McCurdy A., Lacy M. Ther. Adv. Hematol. 2013, 4:211.
191. Lentzsch S., Rogers M., LeBlanc R., Birsner A., Shah J., Treston A., Anderson K., D'Amato R. Cancer Res. 2002, 62:2300.
192. Muller, G.; Stirling, D.; Chen, R. US Patent 5,635,517, 1997.
193. Muller G., Chen R., Huang S., Corral L., Wong L., Patterson R., Chen Y., Kaplan G., Stirling D. Bioorg. Med. Chem. Lett. 1999, 9:1625.
194. Schey S., Fields P., Bartlett J.B., Clarke I., Ashan G., Knight R., Streetly M., Dalgleish A. J. Clin. Oncol. 2004, 22:3269.
195. Hoffmann M., Kasserra C., Reyes J., Schafer P., Kosek J., Capone L., Parton A., Kim-Kang H., Surapaneni S., Kumar G. Cancer Chemother. Pharmacol. 2013, 71:489.
196. Richardson P., Siegel D., Vij R., Hofmeister C., Baz R., Jaganneth S., Chen C., Lonial S., Jakubowiak A., Bahlis N., Song K., Belch A., Raje N., Shustik C., Lentzsch S., Lacy M., Mikhael J., Matous J., Vesole D., Chen M., Zaki M., Jacques C., Yu Z., Anderson K. Blood 2014, 123:1826.
197. Terpos E., Kanellias N., Christoulas D., Kastritis E., Dimopoulos M. Oncol. Targets Ther. 2013, 6:531.
198. (last accessed 15.02.2014). http://www.pomalyst.com/wp-content/uploads/2013/08/prescribing_information.pdf.
199. Piazza G., Goldhaber S.Z. N. Engl. J. Med. 2011, 364:351.
200. Schermuly R.T., Janssen W., Weissmann N., Stasch J.-P., Grimminger F., Ghofrani H.A. Expert Opin. Investig. Drugs 2011, 20:567.
201. Schermuly R.T., Stasch J.P., Pullamsetti S.S., Middendorff R., Muller D., Schluter K.D., Dingendorf A., Hackemack S., Kolosionek E., Kaulen C., Dumitrascu R., Weissmann N., Mittendorf J., Klepetko W., Seeger W., Ghofrani H.A., Grimminger F. Eur. Respir. J. 2008, 32:881.
202. Yoshina S., Tanaka A., Kuo S.-C. Yukugaku Zasshi 1978, 98:204.
203. Mittendorf J., Weigand S., Alonso-Alija C., Bischoff E., Feurer A., Gerisch M., Kern A., Knorr A., Lang D., Muenter K., Radtke M., Schirok H., Schlemmer K.-H., Stahl E., Straub A., Wunder F., Stasch J.-P. ChemMedChem 2009, 4:853.
204. Frey R., Muck W., Unger S., Artmeier-Brandt U., Weimann G., Wensing G. J. Clin. Pharmacol. 2008, 48:926.
205. Ghofrani H.-A., D'Armini A.M., Grimminger F., Hoeper M.M., Jansa P., Kim N.H., Mayer E., Simonneau G., Wilkins M.R., Fritsch A., Neuser D., Weimann G., Wang C. N. Engl. J. Med. 2013, 369:319.
206. Ghofrani H.-A., Galie N., Grimminger F., Grunig E., Humbert M., Jing Z.-C., Keogh A.M., Langleben D., Kilama M.O., Fritsch A., Neuser D., Rubin L. N. Engl. J. Med. 2013, 369:330.
207. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. Lancet 2004, 364:937.
208. Fruchart J.-C., Davignon J., Hermans M.P., Al-Rubeaan K., Amarenco P., Assmann G., Barter P., Betteridge J., Bruckert E., Cuevas A., Farnier M., Ferrannini E., Fioretto P., Gensest J., Ginsberg H.N., Gotto A.M., Hu D., Kadowaki T., Kodama T., Kremp M., Matsuzawa Y., Millán Núñez-Cortés J., Monfil C.C., Ogawa H., Plutzky J., Rader D.J., Sadikot S., Santos R.D., Shlyakhto E., Sritara P., Sy R., Tall A., Tan C.E., Tokgozoglu L., Toth P.P., Valensi P., Wanner C., Zambon A., Zhu J., Zimmet P. Cardiovasc. Diabetol. 2014, 13:1.
209. Stone N.J., Robinson J.G., Lichtenstein A.H., Bairey Merz C.N., Blum C.B., Eckel R.H., Goldberg A.C., Gordon D., Levy D., Lloyd-Jones D.M., McBride P., Schwartz J.S., Shero S.T., Smith S.C., Watson K., Wilson P.W.F. J. Am. Coll. Cardiol. 2014, 63:2889.
210. http://www.lipaglyn.com/downloads/Lipaglyn_Preclinical_Studies.ppsx.
211. Lohray, B. B.; Lohray, V. B.; Barot, V. K. G. USPTO 6,987,123 B2, 2006.
212. Jani R.H., Kansagra K., Jain M.R., Patel H. Clin. Drug Investig. 2013, 33:809.
213. Lipaglyn (accessed 25.03.2014), 2014. http://lipaglyn.com/doctor.html.
214. Jani R.H., Pai V., Jha P., Jariwala G., Mukhopadhyay S., Bhansali A., Joshi S. Diabetes Technol. Ther. 2014, 16:63.
215. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071624.pdf.
216. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022271s000lbl.pdf.
217. Vaidya A., Perry C.M. Drugs 2013, 73:2093.
218. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm376449.htm
219. http://hepcbc.ca/2013/11/galexos-simeprevir-approved-by-health-canada/.
220. Hajarizadeh B., Grebely J., Dore G.J. Nature Rev. Gastroenterol. Hepatol. 2013, 10:553.
221. Raboisson P., de Kock H., Rosenquist A., Nilsson M., Salvador-Oden L., Lin T.-I., Roue N., Ivanov V., Wahling H., Wickstrom K., Hamelink E., Edlund M., Vrang L., Vendeville S., Van de Vreken W., McGowan D., Tahri A., Hu L., Bouton C., Lenz O., Delouvroy F., Pille G., Surleraux D., Wigerinck P., Samuelsson B., Simmen K. Bioorg. Med. Chem. Lett. 2008, 18:4853.
222. Rosenquist A., Samuelsson B., Johansson P.-O., Cummings M.D., Lenz O., Raboisson P., Simmen K., Vendeville S., de Kock H., Nilsson M., Horvath A., Kalmeijer R., de la Rosa G., Beumont-Mauviel M. J. Med. Chem. 2014, 57:1673.
223. Lin T.-I., Lenz O., Fanning G., Verbinnen T., Delouvroy F., Scholliers A., Vermeiren K., Rosenquist A., Edlund M., Samuelsson B., Vrang L., de Kock H., Wigerinck P., Raboisson P., Simmen K. Antimicrob. Agents Chemother. 2009, 53:1377.
224. Reesink H.W., Fanning G.C., Abou Farha K., Weegink C., Van Vliet A., Van't Klooster G., Lenz O., Aharchi F., Marien K., Van Remoortere P., de Kock H., Broeckaert F., Meyvisch P., van Beirendonck E., Simmen K., Verloes R. Gastroenterology 2010, 138:913.
225. Izumi N., Hayashi N., Kumada H., Okanoue T., Tsubouchi H., Yatsuhashi H., Kato M., Ki R., Komada Y., Seto C., Goto S. J. Gastroenterol. 2014, 49:941.
226. Forns X., Lawitz E., Zeuzem S., Gane E., Bronowicki J.P., Andreone P., Horban A., Brown A., Peeters M., Lenz O., Ouwerkerk-Mahadevan S., Scott J., De La Rosa G., Kalmeijer R., Sinha R., Beumont-Mauviel M. Gastroenterology 2014, 146:1669.
227. Jacobson I., Dore G.J., Foster G.R., Fried M.W., Radu M., Rafalskiy V.V., Moroz L., Craxì A., Peeters M., Lenz O., Ouwerkerk-Mahadevan S., Kalmeijer R., Beumont-Mauviel M. J. Hepatol. 2013, 58:S574. Abstract 1425.
228. Manns M., Marcellin P., Poordad F., de Araujo E.S.A., Buti M., Horsmans Y., Ewa Janczewska E.J., Villamil F., Peeters M., Lenz O., Ouwerkerk-Mahadevan S., Kalmeijer R., Beumont-Mauviel M. J. Hepatol. 2013, 58:S568. Abstract 1413.
229. http://www.cdc.gov/HEPATITIS/Statistics/index.htm
230. http://www.who.int/mediacentre/factsheets/fs164/en/.
231. Ahn J., Flamm S.L. Gastroenterol. Hepatol. 2014, 10:90.
232. Sofia M.J., Bao D., Chang W., Du J., Nagarathnam D., Rachakonda S., Ganapati Reddy P., Ross B.S., Wang P., Zhang H.-R., Bansal S., Espirity C., Keilman M., Lam A.M., Micolochick Steuer H.M., Niu C., Otto M.J., Furman P.A. J. Med. Chem. 2010, 53:7202.
233. Murakami E., Tolstykh T., Bao H., Niu C., Micolochick Steuer H.M., Bao D., Chang W., Espiritu C., Bansal S., Lam A.M., Otto M.J., Sofia M.J., Furman P.A. J. Biol. Chem. 2010, 285:34337.
234. Lam A.M., Espiritu C., Bansal S., Micolochick Steuer H.M., Niu C., Zennou V., Keilman M., Zhu Y., Lan S., Otto M.J., Furman P.A. Antimicrob. Agents Chemother. 2012, 56:3359.
235. Ross B.S., Ganapati Reddy P., Zhang H.-R., Rachakonda S., Sofia M.J. J. Org. Chem. 2011, 76:8311.
236. Rodriguez-Torres M., Lawitz E., Kowdley K.V., Nelson D.R., DeJesus E., McHutchison J.G., Cornpropst M.T., Mader M., Albanis E., Jiang D., Hebner C.M., Symonds W.T., Berrey M.M., Lalezari J. J. Hepatol. 2013, 58:663.
237. Denning J., Cornpropst M., Flach S.D., Berrey M.M., Symonds W.T. Antimicrob. Agents Chemother. 2013, 57:1201.
238. Lawitz E., Rodriguez-Torres M., Denning J.M., Albanis E., Cornpropst M., Berrey M.M., Symonds W.T. Antimicrob. Agents Chemother. 2013, 57:1209.
239. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pdf.
240. Jacobson I.M., Gordon S.C., Kowdley K.V., Yoshida E.M., Rodriguez-Torres M., Sulkowski M.S., Shiffman M.L., Lawitz E., Everson G., Bennett M., Schiff E., Tarek Al-Assi M., Subramanian G.M., Lin M., McNally J., Brainard D., Symonds W.T., McHutchison J.G., Patel K., Feld J., Pianko S., Nelson D.R. N. Engl. J. Med. 2013, 368:1867.
241. Lawitz E., Mangia A., Wyles D., Rodriguez-Torres M., Hassanein T., Gordon S.C., Schultz M., Davis M.N., Kayali Z., Reddy K.R., Jacobson I.M., Kowdley K.V., Nyberg L., Subramanian G.M., Hyland R.H., Arterburn S., Jiang D., McNally J., Brainard D., Symonds W.T., McHutchison J.G., Sheikh A.M., Younossi Z., Gane E.J. N. Engl. J. Med. 2013, 368:1878.
242. Culos K.A., Cuellar S. Ann. Pharmacother. 2013, 47:519.
243. McCubrey J.A., Milella M., Tafuri A., Martelli A.M., Lunghi P., Bonati A., Cervello M., Lee J.T., Steelman L.S. Curr. Opin. Investig. Drugs 2008, 9:614.
244. Solit D.B., Garraway L.A., Pratilas C.A., Sawai A., Getz G., Basso A., Ye Q., Lobo J.M., She Y., Osman I., Golub T.R., Sebolt-Leopols J., Sellers W.R., Rosen N. Nature 2006, 439:358.
245. Abe H., Kikuchi S., Hayakawa K., Iida T., Nagahashi N., Maeda K., Sakamoto J., Matsumoto N., Miura T., Matsumura K., Seki N., Inaba T., Kawasaki H., Yamaguchi T., Kakefuda R., Nanayama T., Kurachi H., Hori Y., Yoshida T., Kakegawa J., Watanabe Y., Gilmartin A.G., Richter M.C., Moss K.G., Laquerre S.G. ACS Med. Chem. Lett. 2011, 2:320.
246. Gilmartin A.G., Bleam M.R., Groy A., Moss K.G., Minthorn E.A., Kulkarni S.G., Rominger C.M., Erskine S., Fisher K.E., Yang J., Zappacosta F., Annan R., Sutton D., Laquerre S.G. Clin. Cancer Res. 2011, 17:989.
247. Infante J.R., Fecher L.A., Falchook G.S., Nallapareddy S., Gordon M.S., Becerra C., DeMarini D.J., Cox D.S., Xu Y., Morris S.R., Peddareddigari V.G.R., Le N.T., Hart L., Bendell J.C., Eckhardt G., Kurzrock R., Flaherty K., Burris H.A., Messersmith W.A. Lancet Oncol. 2012, 13:773.
248. Flaherty K.T., Robert C., Hersey P., Nathan P., Garbe C., Milhem M., Demidov L.V., Hassel J.C., Rutkowski P., Mohr P., Dummer R., Trefzer U., Larkin J.M.G., Utikal J., Dreno B., Nyakas M., Middleton M.R., Becker J.C., Casey M., Sherman L.J., Wu F.S., Ouellet D., Martin A.-M., Patel K., Schadendorf D. N. Engl. J. Med. 2012, 367:107.
249. Gibb A., Deeks E.D. Drugs 2014, 74:135.
250. http://www.nimh.nih.gov/statistics/1mdd_adult.shtml.
251. Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G., Murray C.J.L., Vos T., Whiteford H.A. PLoS Med. 2013, 10.1371/journal.pmed.1001547.
252. Bang-Andersen B., Ruhland T., Jørgensen M., Smith G., Frederiksen K., Jensen K.G., Zhong H., Nielsen S.M., Hogg S., Mørk A., Stensbøl T.B. J. Med. Chem. 2011, 54:3206.
253. Mørk A., Pehrson A., Brennum L.T., Møller Nielsen S., Zhong H., Lassen A.B., Miller S., Westrich L., Boyle N.J., Sanchez C., Fischer C.W., Liebenberg N., Wegener G., Bundgaard C., Hogg S., Bang-Andersen B., Stensbøl T.B. J. Pharmacol. Exp. Ther. 2012, 340:666.
254. Christensen, K. Patent Application WO2013/102573, 2013.
255. Areberg J., Søgaard B., Høger A.-M. Basic Clin. Pharmacol. Toxicol. 2012, 111:198.
256. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204447s000lbl.pdf.
257. Henigsberg N., Mahableshwarkar A.R., Jacobsen P., Chen Y., Thase M.E. J. Clin. Psychiatry 2012, 73:953.
258. Boulenger J.-P., Loft H., Olsen C.K. Int. Clin. Physchopharmacol. 2014, 29:138.